MICOXOLAMINA CREAM DERM 30G 1%

MICOXOLAMINA

active ingredients

MICOXOLAMINA 1% CREMA 100 g cream contain: active ingredient Ciclopiroxolamina 1 g. MICOXOLAMINA 1% CUTANEA EMULSION 100 g skin emulsion contain: active ingredient Ciclopiroxolamina 1 g. MICOXOLAMINA 1% CUTANEA 100 g skin solution contain: active ingredient Ciclopiroxolamina 1 g. For excipients, see 6.1

Excellent

CREMA: etylenglycol and polioxyethyleneglycol palmito–stearici, glycerides of polyoxyethylene saturated fatty acids, vaseline oil, benzoic acid, butilidroxyanisolo, purified water. CUTANEA EMULSION: etilenglicol and palmito-stearici polyoxyethylene fatty acids, vaseline oil, benzoic acid, lactic acid, butilidroxyanisolo, purified water. ESTABLISHING: laurilsulfate of monoethanolamine, polyethyleneglycol 150 stearate, polysorbate 20, lecitindietanolamide, sodium edetate, benzilic alcohol, perfume, lactic acid, purified water.

Therapeutic indications

Skin mycosis supported by sensitive mushrooms

Contraindications

Hypersensitivity to the active ingredient or any of the excipients.

Population

The different preparations allow the doctor to adopt the one most suitable for the individual case. Unless different medical prescription, posology is usually the following: Micoxolamine cream and skin emulsion The cream is particularly suitable for glabrous surfaces and limited extensions. Apply 2 or 3 times a day depending on the severity of the pathology, injuries and immediately surrounding areas, with a slight massage. Repeat the treatment until the injury disappears (usually 1–2 weeks). To prevent relapses it is advisable to continue therapy for 1–2 weeks. An occlusive treatment is recommended in the treatment of onicomycosis. Skin solution The skin solution is particularly suitable for the treatment and prevention of pityriasis versicolor, such as sensitive infections of the scalp, such as those from Malassetia sp., seborroic dermatitis and pityriasis capitis (forphore). Apply the solution to areas affected by the infection by a slight massage; let the product act for about 3–5 minutes before rinsing. In the pityriasis versicolor it is recommended to perform treatment from 1 to 3 times a day until the disappearance of lesions, usually for 1–2 weeks. In the pityriasis capitis (forphora) and in the seborrhoic dermatitis of the scalp perform 2–3 treatments per week for 2–4 weeks. According to the doctor, treatment with the skin solution can be continued for an additional 1–2 weeks in order to reduce the risk of relapse.

Conservation

MICOXOLAMINA 1% Cream – None. MICOXOLAMINA 1% Skin emulsion – None. MICOXOLAMINA 1% Skin solution – keep at a temperature not exceeding 25° C.

Warnings

The product should not be used in ophthalmic affections. The cyclopyroxolamine must be used with caution and under the direct control of the doctor: – in case of concomitant systemic antifungal treatment; – in subjects with anamnesi of immunosuppression; – in patients with compromised immune system, such as transplanted subjects and those with HIV infection; – in diabetic subjects. The use, especially if prolonged use of medicines for topical use, can give rise to awareness. In this case it is necessary to suspend treatment and establish suitable therapeutic measures. Hygienic measures recommended by the doctor must be strictly observed during treatment.

Interactions

They're not known.

Effects

Occasionally itching and burning or skin irritation can occur, usually transient.

Overdosing

Given the characteristics of the product, there are no overdose risks.

In pregnant women, during breastfeeding and early childhood, the medicine must be used only in cases of actual need, under the direct control of the doctor.

Source: Farmadati